Clinical Trial Update: Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.

View source ↗

Summary

A clinical trial evaluates CHOP-R therapy for good-prognosis, BCL-6 negative diffuse large B-cell lymphoma in patients under 61 years old.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Non-Hodgkin Lymphoma | Status: UNKNOWN